Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Arcutis Biotherapeutics Inc shares valued at $36,735 were sold by Burnett Patrick on Mar 03 ’25. At $13.03 per share, Burnett Patrick sold 2,819 shares. The insider’s holdings dropped to 167,043 shares worth approximately $2.42 million following the completion of this transaction.
Also, Burnett Patrick sold 954 shares, netting a total of over 12,673 in proceeds. Following the sale of shares at $13.28 each, the insider now holds 166,089 shares.
Before that, Watanabe Todd Franklin had sold 20,880 shares from its account. In a trade valued at $272,089, the insider traded Arcutis Biotherapeutics Inc shares for $13.03 each. Upon closing the transaction, the insider’s holdings decreased to 20,880 shares, worth approximately $13.55 million.
As published in their initiating research note from H.C. Wainwright on December 30, 2024, Arcutis Biotherapeutics Inc [ARQT] has been a Buy and the price target has been revised to $19. Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in late August. As of January 03, 2024, Mizuho has increased its “Neutral” rating to a “Buy” for ARQT. Earlier on October 26, 2023, Mizuho downgraded its rating. Their new recommendation was “a Neutral” for ARQT stock which previously was a “a Buy”.
Analyzing ARQT Stock Performance
During the last five days, there has been a surge of approximately 13.28%. Over the course of the year, Arcutis Biotherapeutics Inc shares have jumped approximately 4.09%. Shares of the company reached a 52-week high of $16.20 on 01/07/25 and a 52-week low of $11.13 on 02/11/25. A 50-day SMA is recorded $13.55, while a 200-day SMA reached $10.79.
Support And Resistance Levels for Arcutis Biotherapeutics Inc (ARQT)
According to the 24-hour chart, there is a support level at 14.13, which, if violated, would cause prices to drop to 13.75. In the upper region, resistance lies at 14.99. The next price resistance is at 15.47. RSI (Relative Strength Index) is 58.25 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.05, which suggests the price will increase in the coming days. Percent R is at 17.91%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
